These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7777495)

  • 21. Gene targeting in human pluripotent stem cells.
    Liu Y; Rao M
    Methods Mol Biol; 2011; 767():355-67. PubMed ID: 21822888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model.
    Welch CL; Bretschger S; Latib N; Bezouevski M; Guo Y; Pleskac N; Liang CP; Barlow C; Dansky H; Breslow JL; Tall AR
    Proc Natl Acad Sci U S A; 2001 Jul; 98(14):7946-51. PubMed ID: 11438740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mice lacking the eNOS gene].
    Moroi M; Namiki A; Huang PL
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():469-73. PubMed ID: 15506429
    [No Abstract]   [Full Text] [Related]  

  • 24. Conditional gene targeting in the mouse nervous system: Insights into brain function and diseases.
    Gavériaux-Ruff C; Kieffer BL
    Pharmacol Ther; 2007 Mar; 113(3):619-34. PubMed ID: 17289150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene targeting in the mouse.
    Melton DW
    Bioessays; 1994 Sep; 16(9):633-8. PubMed ID: 7980488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genetic aspect of essential hypertension].
    Umemura S
    Rinsho Byori; 2003 Aug; 51(8):813-7. PubMed ID: 13677943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequence-specific modification of mouse genomic DNA mediated by gene targeting techniques.
    Sangiuolo F; Novelli G
    Cytogenet Genome Res; 2004; 105(2-4):435-41. PubMed ID: 15237231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. G protein polymorphisms in hypertension, atherosclerosis, and diabetes.
    Siffert W
    Annu Rev Med; 2005; 56():17-28. PubMed ID: 15660499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular and cellular mechanisms of arteriosclerosis and restenosis: possibilities of gene therapy].
    Lüscher TF; Oemar BS; Yang Z; Noll G
    Z Kardiol; 1996 Jul; 85(7):495-508. PubMed ID: 8928548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laminopathies and atherosclerosis.
    Al-Shali KZ; Hegele RA
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1591-5. PubMed ID: 15205220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic aspects of hypertension and metabolic disease in the obstructive sleep apnoea-hypopnoea syndrome.
    Riha RL; Diefenbach K; Jennum P; McNicholas WT;
    Sleep Med Rev; 2008 Feb; 12(1):49-63. PubMed ID: 18201663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mouse strain-specific differences in vascular wall gene expression and their relationship to vascular disease.
    Tabibiazar R; Wagner RA; Spin JM; Ashley EA; Narasimhan B; Rubin EM; Efron B; Tsao PS; Tibshirani R; Quertermous T
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):302-8. PubMed ID: 15550693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of a mouse with low galactocerebrosidase activity by gene targeting: a new model of globoid cell leukodystrophy (Krabbe disease).
    Luzi P; Rafi MA; Zaka M; Curtis M; Vanier MT; Wenger DA
    Mol Genet Metab; 2001 Jul; 73(3):211-23. PubMed ID: 11461188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-converting enzyme 2 as a novel target for gene therapy for hypertension.
    Katovich MJ; Grobe JL; Huentelman M; Raizada MK
    Exp Physiol; 2005 May; 90(3):299-305. PubMed ID: 15640278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional genomics in hypertension.
    McBride MW; Graham D; Delles C; Dominiczak AF
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):145-51. PubMed ID: 16481881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of the genetics of essential hypertension.
    Binder A
    Curr Opin Cardiol; 2007 May; 22(3):176-84. PubMed ID: 17413273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transgenics and essential hypertension.
    Mullins LJ; Morley SD; Mullins JJ
    J Hum Hypertens; 1996 Oct; 10(10):627-31. PubMed ID: 9004085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Candidate genes, small effects, and the prediction of atherosclerosis.
    Hegele RA
    Crit Rev Clin Lab Sci; 1997; 34(4):343-67. PubMed ID: 9288444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiology of gene-targeted mouse models for cystic fibrosis.
    Grubb BR; Boucher RC
    Physiol Rev; 1999 Jan; 79(1 Suppl):S193-214. PubMed ID: 9922382
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.